Albuquerque, New Mexico 5/12/2011 – Indica Labs, Inc. receives an initial round of seed funding to begin product development of a series of image analysis tools for digital pathology. The venture backed company will immediately begin development operations in the Albuquerque, New Mexico area.
Traditional pathology methods typically involve manual assessment of glass slides under a microscope. But the recent emergence of new technologies such as whole-slide scanners and image management systems has made digitization of glass slides commonplace. This digital transformation has led to an increasing need for whole-slide image analysis software and visualization tools.
“Our software will address the growing demand for sophisticated image processing algorithms that will aid pathologists in reaching an accurate assessment more efficiently and effectively as well as assist researchers and scientists in generating highly reproducible and quantitative data” says CEO, Steven Hashagen. “The number of institutions that have invested in digital pathology hardware and software systems is rapidly growing, and our tools will allow these institutions to leverage more value out of their investments”.
Indica Labs’ initial product offering will include a set of digital pathology software tools that will be used by pathologists in academic medical centers, government research institutions, global pharmaceutical companies, and small biotech firms.
For more information, please visit www.indicalab.com.
About Indica Labs, Inc.
Indica Labs provides sophisticated image analysis software for digital pathology. Indica Labs' software tools seamlessly integrate into leading digital pathology platforms to provide reproducible and highly quantitative data to pathologists in hospitals, academic medical centers, government research institutions, global pharmaceutical companies, and small biotech firms.
Indica Labs, Inc.